论文部分内容阅读
目的:探讨三种喹诺酮类药治疗女性非淋菌性尿道(宫颈)炎的经济成本。方法:选择60例女性非淋菌性尿道(宫颈)炎患者,随机分为3组,分别给予左氧氟沙星(A组)、加替沙星(B组)、司帕沙星(C组)治疗。运用药物经济学的成本-效果分析方法进行评价。结果:A组、B组、C组所需药品成本分别是72.24,111.16,133.00元。有效率分别是85.00%,86.36%,88.89%。结论:根据药物经济学成本-效果分析,左氧氟沙星是治疗女性非淋菌性尿道(宫颈)炎的最佳药物。
Objective: To investigate the economic costs of three quinolones in the treatment of female non-gonococcal urethritis (cervix) inflammation. Methods: Sixty female patients with non-gonococcal urethritis (cervix) were selected and randomly divided into three groups. Patients were treated with levofloxacin (group A), gatifloxacin (group B) and sparfloxacin (group C). Use cost-effectiveness analysis of pharmacoeconomics to evaluate. Results: The costs of medicines required for group A, group B and group C were 72.24, 111.16 and 133.00 yuan respectively. The effective rates are respectively 85.00%, 86.36% and 88.89%. Conclusions: Levofloxacin is the best treatment for non-gonococcal urethritis (cervix) in women based on the cost-effectiveness analysis of pharmacoeconomics.